it is fairly obvious that the share price is sensitive to the progress of oxypatch.
we are at a similar point in time in oxypatch progress as we were 12 months ago, due to the now resolved crystalisation problem, hence the similar share price.
IMO, once we hit multi-dosing we will start our journey back to the mid twenties, the difference being a new kid on the block, oxymorphone and the next price sensitive major development - mastitis.
Jan 3rd is not the time to expect a rally but within 2 weeks i expect people to start taking their seats at the table.
poh: an alternative review of 2012, page-11
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |